1. FDA-2003-D-0032: Guidance for Industry PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance, September 2004. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance. Accessed on 19/7/2020.
2. ICH guideline Q8 (R2) on pharmaceutical development (harmonised tripartite guideline), August 2009. https://www.ema.europa.eu/en/ich-q8-r2-pharmaceutical-development#current-effective-version-section. Accessed on 12/12/2020.
3. Robust method optimization strategy—A useful tool for method transfer: The case of SFC;Dispas;J. Pharmaceut. Biomed.,2014
4. The application of quality by design to analytical methods;Borman;Pharm. Technol.,2007
5. Application of quality by design to the development of analytical separation methods;Orlandini;Anal. Bioanal. Chem.,2013